|
| Exchange Disseminated Time 02/06/2016 15:04:22 | With reference to the earlier letter dated May 26, 2016 regarding the meeting of Board of Directors of the Company which was scheduled on June 06, 2016, inter alia, to consider and approve the allotment of 14,50,000 Equity Shares on conversion of remaining 14,50,000 Share Warrants which were allotted on preferential basis to Shri JB Pharma LLP, (“Promoter” or “Proposed Allottee”) on September 28, 2015 and the issue of which was approved by the shareholders at 42nd Annual General Meeting of the Company held on September 03, 2015., in Compliance with SEBI (ICDR) Regulations, 2009, Companies Act, 2013 and other applicable laws, rules and regulations and any other business with the permission of the chair..
In this regard, Mangalam Drugs & Organics Ltd has now informed BSE that that due to unavoidable circumstances the meeting of Board of Directors is postponed and re-scheduled to June 10, 2016 at 11.30 AM at the registered office of Company.
Further, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and in terms of the Company’s Code of Conduct for Regulating, Monitoring, and Reporting Trading By insiders, the Trading Window for dealing in Equity Shares of the Company shall now remain closed upto the expiry of 48 hours from the time the Outcome is communicated to the Stock Exchanges on the date of the Meeting i.e. June 10, 2016. |
|
|